| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9308443 | Kidney International | 2005 | 5 Pages |
Abstract
Tacrolimus is an effective option for induction treatment of SLE-diffuse proliferative glomerulonephritis. Further trials are necessary to determine the optimal dosage and duration of therapy, and its efficacy in comparison to standard regimens.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
C.H.I. Chiu Mok, K.A. Hang Tong, C.H.I. Hung To, Y.U.I. Pong Siu, T.A.K. Cheung Au,